NR4A1 and breast cancer: Despite only accounting for about 15–20% of all breast cancers (BCs), the hormone receptor (HR)-negative subtype, that is, estrogen receptor (ER) and progesterone receptor (PgR) negative, causes a disproportionate number of BC-related deaths the first 5 years after diagnosis [1].